Biventricular Remodeling in Transcatheter Tricuspid Valve Replacement - Acute Hemodynamic Instability Study

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT06954792
Status
Enrolling By Invitation

Conditions

  • Heart Failure
  • Interventional Cardiology
  • Structural Heart Disease
  • Tricuspid Regurgitation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

TTVR-AHI is a multicenter, retrospective registry including heart failure patients displaying a severe and symptomatic tricuspid regurgitation (TR), deemed non-eligible to cardiac surgery and therefore treated with transcatheter tricuspid valve replacement (TTVR) devices. This substudy of the main registry will focus on those with post-procedural acute hemodynamic instability (AHI).

Key Dates

Start date
Jan 31, 2027
Status verified
Feb 2026
Primary completion
May 1, 2029
Completion
May 1, 2029

Study Design

Enrollment
140 participants (estimated)

Arms

  • Arm: No AHI
    Patients undergoing TTVR without presenting any AHI post-procedurally
  • Arm: AHI
    Patients undergoing TTVR and presenting AHI within 24h after the procedure

Primary Outcome Measure

Mortality Rate [ Time Frame: 1 Year ]

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Medical CenterNew YorkNew York10032-

Find similar trials in New York, NY

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Columbia University Medical Center· New York, NY

Related Studies